These results suggested that the activity of the SP1/NFY transcriptional complex on the PNPT1 promoter could be relevant for tumor growth and for the survival of liver cancer cells; they also suggested that there must be a pathological context in which the activity of the PNPT1 promoter depends on both SP1 and NFY, rather than just SP1. This evidence concerns the gene PNPT1 and liver cancer.